“Erlina (Empagliflozin+Linaglipton) 10/5mg Tablets” has been added to your basket.
View basket
Showing 1–24 of 136 resultsSorted by latest
-
₨ 2,950 – ₨ 6,500Price range: ₨ 2,950 through ₨ 6,500Zeptide Injections in Pakistan:
Zeptide is Pakistan’s most affordable tirzepatide brand (Mounjaro® alternative), manufactured by Ferozsons.
It is a once-weekly injection used to improve blood sugar control in Type 2 Diabetes and supports significant weight loss when combined with diet and lifestyle changes.
Available in:
- 2.5 mg,
- 5 mg,
- 7.5 mg,
- 10 mg,
- 12.5 mg, and
- 15 mg once weekly injections at affordable prices.
Common side effects include nausea, vomiting, stomach upset, and decreased appetite.
Not for Type 1 diabetes or during pregnancy.
It is a prescription-only medicine.
-
₨ 3,150Semhil 3 mg (Oral Semaglutide) – Hilton Pharma
Semhil 3 mg is an oral form of semaglutide used to help manage type 2 diabetes and support weight loss by improving blood sugar control and reducing appetite.
Convenient and effective, it offers the benefits of injectable GLP-1 therapy in a tablet form.
Brand Name: Semhil
Manufacturer Name: Hilton Pharma
Semhil Price: PKR: 3150 per pack
Pack: Each Pack contains 14 tablets
Recommended Use: Best to take it on an empty stomach with 2 glasses of water
Available at A+ Pharmacy – Home delivery, and expert guidance.
-
₨ 4,000 – ₨ 10,000Price range: ₨ 4,000 through ₨ 10,000Tirzee Injection – Mounjaro (Tirzepatide) Alternative in Pakistan | Getz Pharma
Tirzee Injection contains Tirzepatide, a dual GIP and GLP-1 receptor agonist developed by Getz Pharma as a locally manufactured alternative to Mounjaro. It is used for the management of type 2 diabetes and supports effective weight loss when combined with diet and exercise.
Product Details:
- Generic: Tirzepatide
- Brand: Tirzee
- Manufacturer: Getz Pharma
- Available Strengths & Prices:
- 2.5 mg pen – Rs. 4,000
- 5 mg pen – Rs. 6,000
- 7.5 mg pen – Rs. 7,500
- 10 mg pen – Rs. 10,000
- Administration: Once-weekly subcutaneous injection
✅ Helps lower blood sugar levels
✅ Promotes significant and sustained weight loss
✅ Convenient once-weekly dosing
✅ Cost-effective Mounjaro alternative in Pakistan
Use under medical supervision only. Not suitable for individuals with a history of thyroid cancer or pancreatitis.
-
₨ 2,450 – ₨ 5,740Price range: ₨ 2,450 through ₨ 5,740SemO Tablets 3 mg – Oral Semaglutide (Ozempic & Rybelsus Alternative)
SemO Tablets contain 3 mg of oral semaglutide (Generic: Semaglutide), a clinically proven GLP-1 receptor agonist that helps control blood sugar levels and supports healthy weight loss in adults with type 2 diabetes.
Designed as an oral alternative to Ozempic and equivalent to Rybelsus, SemO offers effective diabetes and weight management in a simple once-daily tablet.
Product Details:
- Generic: Semaglutide
- Brand: SemO
- Manufacturer: Getz Pharma
- Tablets per Pack: 14
- How to Take: Swallow with two glasses of water, 30 minutes before the first meal of the day
✅ Helps lower blood glucose levels
✅ Supports appetite control and gradual weight loss
✅ Convenient oral formulation—no injections required
✅ Trusted alternative to Rybelsus
Use only under medical supervision. Not recommended for individuals with a history of thyroid cancer or pancreatitis.
-
Brand Name: Inosita Plus
Generic Name: Sitagliptin + Metformin HCl
Dosage Strength: 50mg Sitagliptin + 850mg Metformin HCl
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 28 Tablets
Description and Usage:
Inosita Plus (Sitagliptin+Metformin HCl) 50/850mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.
- Sitagliptin: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
- Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.
-
Brand Name: Inosita Plus
Generic Name: Sitagliptin + Metformin HCl
Dosage Strength: 50mg Sitagliptin + 500mg Metformin HCl
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 28 Tablets
Description and Usage:
Inosita Plus (Sitagliptin+Metformin HCl) 50/500mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.
- Sitagliptin: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
- Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.
-
Brand Name: ?
Generic Name: Vildagliptin + Metformin HCl
Dosage Strength: 50mg Vildagliptin + 1000mg Metformin HCl
Manufacturer: Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Galvecta Plus (Vildagliptin+Metformin HCl) 50/1000mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.
- Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
- Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.
-
Brand Name: Galvecta Plus
Generic Name: Vildagliptin + Metformin HCl
Dosage Strength: 50mg Vildagliptin + 500mg Metformin HCl
Manufacturer: Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Galvecta Plus (Vildagliptin+Metformin HCl) 50/500mg Tablets are indicated for the management of type 2 diabetes mellitus in adults. This combination medication helps to control blood sugar levels by multiple mechanisms of action.
- Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
- Metformin Hydrochloride: Metformin is a biguanide medication that works primarily by decreasing hepatic glucose production and increasing peripheral glucose uptake and utilization. It also improves insulin sensitivity in peripheral tissues such as muscle and adipose tissue.
-
Brand Name: Inosita Plus XR
Generic Name: Sitagliptin + Metformin HCl
Dosage Strength: 100mg Sitagliptin + 1000mg Metformin HCl
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets Extended Release
Description and Usage:
Inosita Plus XR tablets combine two active ingredients: Sitagliptin and Metformin Hydrochloride (HCl). This combination medication is used in the treatment of type 2 diabetes mellitus to help control blood sugar levels.
Inosita Plus XR (Sitagliptin+Metformin HCl) tablets are indicated for the management of type 2 diabetes mellitus in adults. This medication helps to control blood sugar levels by multiple mechanisms of action, including increasing insulin secretion and reducing hepatic glucose production.
- Sitagliptin: Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), leading to increased levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This results in enhanced insulin secretion and decreased glucagon release, ultimately reducing blood glucose levels.
- Metformin Hydrochloride: Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
-
₨ 1,255Brand Name: Inosita Plus XR
Generic Name: Sitagliptin + Metformin HCl
Dosage Strength: 50mg Sitagliptin + 1000mg Metformin HCl
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets Extended Release
Description and Usage:
Inosita Plus XR tablets combine two active ingredients: Sitagliptin and Metformin Hydrochloride (HCl). This combination medication is used in the treatment of type 2 diabetes mellitus to help control blood sugar levels.
Inosita Plus XR (Sitagliptin+Metformin HCl) tablets are indicated for the management of type 2 diabetes mellitus in adults. This medication helps to control blood sugar levels by multiple mechanisms of action, including increasing insulin secretion and reducing hepatic glucose production.
- Sitagliptin: Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), leading to increased levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This results in enhanced insulin secretion and decreased glucagon release, ultimately reducing blood glucose levels.
- Metformin Hydrochloride: Decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.
-
Brand Name: Inosita
Generic Name: Sitagliptin
Dosage Strength: 100mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 28 Tablets
Description and Usage:
Sitagliptin, commonly known by its brand name Inosita, is a medication primarily used to treat type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Sitagliptin works by increasing the levels of incretin hormones in the body, which help to regulate blood sugar levels by stimulating the release of insulin and decreasing the production of glucagon.
Sitagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
-
Brand Name: Inosita
Generic Name: Sitagliptin
Dosage Strength: 50mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 28 Tablets
Description and Usage:
Sitagliptin, commonly known by its brand name Inosita, is a medication primarily used to treat type 2 diabetes mellitus. It belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. Sitagliptin works by increasing the levels of incretin hormones in the body, which help to regulate blood sugar levels by stimulating the release of insulin and decreasing the production of glucagon.
Sitagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which in turn increases the levels of incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate insulin release from pancreatic beta cells and decrease glucagon secretion from pancreatic alpha cells, thereby reducing blood glucose levels.
-
₨ 812Brand Name: Erlina
Generic Name: Empagliflozin and Linagliptin
Dosage Strength: 25mg Empagliflozin and 5mg Linagliptin
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Erlina is a medication brand that typically contains a combination of two active ingredients: Empagliflozin and Linagliptin, in 25/5mg tablet form. Empagliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, while Linagliptin belongs to the class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
The combination of Empagliflozin and Linagliptin in Erlina tablets provides complementary mechanisms of action to help improve glycemic control in patients with type 2 diabetes mellitus. Empagliflozin works by promoting the excretion of excess glucose in the urine, while Linagliptin works by increasing insulin secretion and decreasing glucagon release from the pancreas.
-
₨ 574Brand Name: Erlina
Generic Name: Empagliflozin and Linagliptin
Dosage Strength: 10mg Empagliflozin and 5mg Linagliptin
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Erlina is a medication brand that typically contains a combination of two active ingredients: Empagliflozin and Linagliptin, in 10/5mg tablet form. Empagliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors, while Linagliptin belongs to the class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
The combination of Empagliflozin and Linagliptin in Erlina tablets provides complementary mechanisms of action to help improve glycemic control in patients with type 2 diabetes mellitus. Empagliflozin works by promoting the excretion of excess glucose in the urine, while Linagliptin works by increasing insulin secretion and decreasing glucagon release from the pancreas.
-
Brand Name: Eglaro
Generic Name: Ertugliflozin
Dosage Strength: 15mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Eglaro is a medication brand that typically contains the active ingredient Ertugliflozin in 15mg tablet form. Ertugliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Here’s a description of Ertugliflozin and its potential effects:
Ertugliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. These drugs work by inhibiting the reabsorption of glucose in the kidneys, thereby increasing the excretion of glucose in the urine and lowering blood sugar levels.
Ertugliflozin works by blocking the SGLT2 protein in the kidneys, which is responsible for the reabsorption of glucose back into the bloodstream. By inhibiting this protein, ertugliflozin promotes the excretion of excess glucose in the urine, leading to a reduction in blood sugar levels.
-
Brand Name: Dapwiz
Generic Name: Dapagliflozin
Dosage Strength: 10mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 10 Tablets
Description and Usage:
Dapwiz is a medication brand that typically contains the active ingredient Dapagliflozin in 10mg tablet form. Dapagliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Here’s a description of Dapagliflozin and its potential effects:
Dapagliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. These drugs work by inhibiting the reabsorption of glucose in the kidneys, thereby increasing the excretion of glucose in the urine and lowering blood sugar levels.
Dapagliflozin works by blocking the SGLT2 protein in the kidneys, which is responsible for the reabsorption of glucose back into the bloodstream. By inhibiting this protein, dapagliflozin promotes the excretion of excess glucose in the urine, leading to a reduction in blood sugar levels.
-
Brand Name: Dapwiz
Generic Name: Dapagliflozin
Dosage Strength: 5mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 10 Tablets
Description and Usage:
Dapwiz is a medication brand that typically contains the active ingredient Dapagliflozin in 5mg tablet form. Dapagliflozin belongs to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. Here’s a description of Dapagliflozin and its potential effects:
Dapagliflozin belongs to the class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. These drugs work by inhibiting the reabsorption of glucose in the kidneys, thereby increasing the excretion of glucose in the urine and lowering blood sugar levels.
Dapagliflozin works by blocking the SGLT2 protein in the kidneys, which is responsible for the reabsorption of glucose back into the bloodstream. By inhibiting this protein, dapagliflozin promotes the excretion of excess glucose in the urine, leading to a reduction in blood sugar levels.
-
Brand Name: Viglip-M
Generic Name: Vildagliptin + Metformin
Dosage Strength: 50mg Vildagliptin + 1000mg Metformin
Manufacturer: Atco Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Viglip-M (Vildagliptin + Metformin) 50mg/1000mg tablets are prescribed for the treatment of type 2 diabetes mellitus in adults. It combines the effects of two different classes of antidiabetic medications:
- Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which help to lower blood sugar levels by stimulating insulin release and reducing glucagon secretion.
- Metformin: Metformin is a biguanide antidiabetic medication. It works by decreasing glucose production in the liver, improving insulin sensitivity in peripheral tissues, and reducing intestinal glucose absorption.
- Vildagliptin: Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which increases the levels of incretin hormones (such as glucagon-like peptide-1 or GLP-1 and glucose-dependent insulinotropic polypeptide or GIP). These hormones stimulate insulin release and suppress glucagon secretion, thereby lowering blood sugar levels.
- Metformin: Decreases hepatic glucose production, enhances peripheral glucose uptake and utilization, and reduces intestinal glucose absorption. These actions collectively help to lower blood glucose levels in patients with type 2 diabetes.
-
Brand Name: Viglip-M
Generic Name: Vildagliptin + Metformin
Dosage Strength: 50mg Vildagliptin + 850mg Metformin
Manufacturer: Atco Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Viglip-M (Vildagliptin + Metformin) 50mg/850mg tablets are prescribed for the treatment of type 2 diabetes mellitus in adults. It combines the effects of two different classes of antidiabetic medications:
- Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which help to lower blood sugar levels by stimulating insulin release and reducing glucagon secretion.
- Metformin: Metformin is a biguanide antidiabetic medication. It works by decreasing glucose production in the liver, improving insulin sensitivity in peripheral tissues, and reducing intestinal glucose absorption.
- Vildagliptin: Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which increases the levels of incretin hormones (such as glucagon-like peptide-1 or GLP-1 and glucose-dependent insulinotropic polypeptide or GIP). These hormones stimulate insulin release and suppress glucagon secretion, thereby lowering blood sugar levels.
- Metformin: Decreases hepatic glucose production, enhances peripheral glucose uptake and utilization, and reduces intestinal glucose absorption. These actions collectively help to lower blood glucose levels in patients with type 2 diabetes.
-
Brand Name: Viglip-M
Generic Name: Vildagliptin + Metformin
Dosage Strength: 50mg Vildagliptin + 500mg Metformin
Manufacturer: Atco Pharmaceutical (Pvt) Ltd.
Packing: 14 Tablets
Description and Usage:
Viglip-M (Vildagliptin + Metformin) 50mg/500mg tablets are prescribed for the treatment of type 2 diabetes mellitus in adults. It combines the effects of two different classes of antidiabetic medications:
- Vildagliptin: Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by increasing the levels of incretin hormones in the body, which help to lower blood sugar levels by stimulating insulin release and reducing glucagon secretion.
- Metformin: Metformin is a biguanide antidiabetic medication. It works by decreasing glucose production in the liver, improving insulin sensitivity in peripheral tissues, and reducing intestinal glucose absorption.
- Vildagliptin: Inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which increases the levels of incretin hormones (such as glucagon-like peptide-1 or GLP-1 and glucose-dependent insulinotropic polypeptide or GIP). These hormones stimulate insulin release and suppress glucagon secretion, thereby lowering blood sugar levels.
- Metformin: Decreases hepatic glucose production, enhances peripheral glucose uptake and utilization, and reduces intestinal glucose absorption. These actions collectively help to lower blood glucose levels in patients with type 2 diabetes.
-
Brand Name: Evopride Plus
Generic Name: Glimepiride + Metformin HCl
Dosage Strength: 2mg Glimepiride + 500mg Metformin HCl
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 30 Tablets
Description and Usage:
Evopride Plus (Glimepiride + Metformin HCl) 2mg/500mg Tablets are a combination medication containing two active ingredients: Glimepiride, a sulfonylurea antidiabetic agent, and Metformin Hydrochloride, a biguanide antidiabetic agent. This combination is used to treat type 2 diabetes mellitus by helping to control blood sugar levels through different mechanisms of action.
- Evopride Plus (Glimepiride + Metformin HCl) 2mg/500mg Tablets are indicated for the management of type 2 diabetes mellitus in adults.
- This combination medication is typically prescribed when treatment with either Glimepiride or Metformin alone has not provided adequate blood sugar control.
-
Brand Name: Evopride Plus
Generic Name: Glimepiride + Metformin HCl
Dosage Strength: 1mg Glimepiride + 500mg Metformin HCl
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 30 Tablets
Description and Usage:
Evopride Plus (Glimepiride + Metformin HCl) 1mg/500mg Tablets are a combination medication containing two active ingredients: Glimepiride, a sulfonylurea antidiabetic agent, and Metformin Hydrochloride, a biguanide antidiabetic agent. This combination is used to treat type 2 diabetes mellitus by helping to control blood sugar levels through different mechanisms of action.
- Evopride Plus (Glimepiride + Metformin HCl) 1mg/500mg Tablets are indicated for the management of type 2 diabetes mellitus in adults.
- This combination medication is typically prescribed when treatment with either Glimepiride or Metformin alone has not provided adequate blood sugar control.
-
Brand Name: Evopride
Generic Name: Glimepiride
Dosage Strength: 4mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 30 Tablets
Description and Usage:
Evopride (Glimepiride) 4mg Tablets contain the active ingredient Glimepiride, which belongs to the class of sulfonylurea antidiabetic medications. Glimepiride works by stimulating the release of insulin from the pancreas, which helps lower blood sugar levels in patients with type 2 diabetes mellitus.
- Evopride (Glimepiride) 4mg Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- It is typically prescribed when lifestyle modifications alone have not provided adequate blood sugar control.
-
Brand Name: Evopride
Generic Name: Glimepiride
Dosage Strength: 3mg
Manufacturer: PharmaEvo Pharmaceutical (Pvt) Ltd.
Packing: 30 Tablets
Description and Usage:
Evopride (Glimepiride) 3mg Tablets contain the active ingredient Glimepiride, which belongs to the class of sulfonylurea antidiabetic medications. Glimepiride works by stimulating the release of insulin from the pancreas, which helps lower blood sugar levels in patients with type 2 diabetes mellitus.
- Evopride (Glimepiride) 3mg Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
- It is typically prescribed when lifestyle modifications alone have not provided adequate blood sugar control.
